Brief: Adaptive Biotechnologies Q3 EPS USD -0.35
09/11/2023 21:05
Nov 09 (Reuters) - Adaptive Biotechnologies Q3 net income USD -50.326 million. * Q3 operating expenses USD 88.875 million * Q3 operating income USD -50.956 million * Q3 revenue USD 37.919 million vs. IBES estimate USD 43 million * Q3 adjusted EBITDA USD -29.8 million * outlook FY revenue USD 100-105 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile